The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
176 jobs Number of planned job losses
Announcement Date
16 September 2013
Employment effect (start)
14 January 2014
Foreseen end date
31 December 2014
Description
Pharmaceuticals company Janssen is to to cut about 176 of its 420 staff. This is mainly to affect sales and executive positions in the French headquarter at Issy-les-Moulineaux. 43 of the positions are already vacant.
The company lost the patent for one of its key products and faces a decline in sales.
The restructuring was initially announced to the works council on 16 September. Negotiations to conclude a social plan are to last until 14 January 2014.
The management has opened discussions with unions to create new activities that could lead to the creation of 34 positions, but the timeframe is unknown.
The company employs a total of 1,435 people in France. It is a subsidiary of the US group Johnson & Johnson.
Sources
3 December 2013: L'usine Nouvelle
5 December 2013: Le Quotidien du médecin
Citation
Eurofound (2013), Janssen, Internal restructuring in France, factsheet number 76303, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76303.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
